101 related articles for article (PubMed ID: 11560253)
1. Greater expression of transforming growth factor alpha and proliferating cell nuclear antigen staining in mouse hepatoblastomas than hepatocellular carcinomas induced by a diethylnitrosamine-sodium phenobarbital regimen.
Sakairi T; Kobayashi K; Goto K; Okada M; Kusakabe M; Tsuchiya T; Sugimoto J; Sano F; Mutai M
Toxicol Pathol; 2001; 29(4):479-82. PubMed ID: 11560253
[TBL] [Abstract][Full Text] [Related]
2. Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital.
Tamano S; Merlino GT; Ward JM
Carcinogenesis; 1994 Sep; 15(9):1791-8. PubMed ID: 7923571
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical localization of transforming growth factor alpha in chemically induced rat hepatocellular carcinomas with reference to differentiation and proliferation.
Kobayashi K; Kusakabe M; Okada M; Sakairi T; Goto K; Tsuchiya T; Sugimoto J; Sano F; Mutai M
Toxicol Pathol; 2000; 28(5):664-7. PubMed ID: 11026601
[TBL] [Abstract][Full Text] [Related]
4. Quantitative relationship between transforming growth factor-alpha and hepatic focal phenotype and progression in female mouse liver.
Moser GJ; Wolf DC; Goldsworthy TL
Toxicol Pathol; 1997; 25(3):275-83. PubMed ID: 9210259
[TBL] [Abstract][Full Text] [Related]
5. Growth kinetic study of human hepatocellular carcinoma using proliferating cell nuclear antigen and Lewis Y antigen: their correlation with transforming growth factor-alpha and beta 1.
Yamaguchi M; Yu L; Hishikawa Y; Yamanoi A; Kubota H; Nagasue N
Oncology; 1997; 54(3):245-51. PubMed ID: 9143407
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical characterization of hepatoblastomas in B6C3F1 mice treated with diethylnitrosamine and sodium phenobarbital.
Sakairi T; Kobayashi K; Goto K; Okada M; Kusakabe M; Tsuchiya T; Sugimoto J; Sano F; Mutai M; Morohashi T
J Vet Med Sci; 2001 Oct; 63(10):1121-5. PubMed ID: 11714029
[TBL] [Abstract][Full Text] [Related]
7. Expression of ErbB receptor proteins and TGF-alpha during diethylnitrosamine-induced hepatocarcinogenesis in the rat liver.
Lee TY; Kim KT; Han SY
Korean J Hepatol; 2007 Mar; 13(1):70-80. PubMed ID: 17380077
[TBL] [Abstract][Full Text] [Related]
8. Expression of transforming growth factor-alpha in hepatoblastoma.
Kiss A; Szepesi A; Lotz G; Nagy P; Schaff Z
Cancer; 1998 Aug; 83(4):690-7. PubMed ID: 9708932
[TBL] [Abstract][Full Text] [Related]
9. Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital.
Calvisi DF; Ladu S; Factor VM; Thorgeirsson SS
Carcinogenesis; 2004 Jun; 25(6):901-8. PubMed ID: 14742323
[TBL] [Abstract][Full Text] [Related]
10. Comparison in C3H and C3B6F1 mice of the sensitivity to diethylnitrosamine-initiation and phenobarbital-promotion to the extent of cell proliferation.
Pereira MA
Carcinogenesis; 1993 Feb; 14(2):299-302. PubMed ID: 8382116
[TBL] [Abstract][Full Text] [Related]
11. Cell expression patterns of CD147 in N-diethylnitrosamine/phenobarbital-induced mouse hepatocellular carcinoma.
Lu M; Wu J; He F; Wang XL; Li C; Chen ZN; Bian H
J Mol Histol; 2015 Feb; 46(1):79-91. PubMed ID: 25447507
[TBL] [Abstract][Full Text] [Related]
12. Lack of promoting effects of phenobarbital at low dose on diethylnitrosamine-induced hepatocarcinogenesis in TGF-alpha transgenic mice.
Puatanachokchai R; Kakuni M; Wanibuchi H; Kinoshita A; Kang JS; Salim EI; Morimura K; Tamano S; Merlino GT; Fukushima S
Asian Pac J Cancer Prev; 2006; 7(2):274-8. PubMed ID: 16839222
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-alpha in carcinogen-induced F344 rat hepatic foci.
Steinmetz KL; Klaunig JE
Toxicol Appl Pharmacol; 1996 Sep; 140(1):131-45. PubMed ID: 8806879
[TBL] [Abstract][Full Text] [Related]
14. Synergy between transforming growth factor alpha and hepatitis B virus surface antigen in hepatocellular proliferation and carcinogenesis.
Jakubczak JL; Chisari FV; Merlino G
Cancer Res; 1997 Aug; 57(16):3606-11. PubMed ID: 9270035
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-alpha expression is altered during experimental hepatocarcinogenesis.
Burr AW; Toole K; Mathew J; Hines JE; Chapman C; Burt AD
J Pathol; 1996 Jul; 179(3):276-82. PubMed ID: 8774483
[TBL] [Abstract][Full Text] [Related]
16. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade.
Calvisi DF; Factor VM; Loi R; Thorgeirsson SS
Cancer Res; 2001 Mar; 61(5):2085-91. PubMed ID: 11280770
[TBL] [Abstract][Full Text] [Related]
17. Further evidence for promoter-dependent development of hepatoblastoma in the mouse.
Diwan BA; Henneman JR; Rice JM
Cancer Lett; 1995 Feb; 89(1):29-35. PubMed ID: 7882299
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-alpha, epidermal growth factor receptor, and PCNA immunoexpression in uterine leiomyosarcomas and leiomyomas in B6C3F1 mice.
Moore AB; He H; Yoshida A; Rico PJ; Haseman JK; Dixon D
Exp Toxicol Pathol; 2000 Jun; 52(3):195-200. PubMed ID: 10930119
[TBL] [Abstract][Full Text] [Related]
19. Abundant TGF alpha precursor and EGF receptor expression as a possible mechanism for the preferential growth of carcinogen-induced preneoplastic and neoplastic hepatocytes in rats.
Tanno S; Ogawa K
Carcinogenesis; 1994 Aug; 15(8):1689-94. PubMed ID: 7914477
[TBL] [Abstract][Full Text] [Related]
20. Liver specific overexpression of platelet-derived growth factor-B accelerates liver cancer development in chemically induced liver carcinogenesis.
Maass T; Thieringer FR; Mann A; Longerich T; Schirmacher P; Strand D; Hansen T; Galle PR; Teufel A; Kanzler S
Int J Cancer; 2011 Mar; 128(6):1259-68. PubMed ID: 20506153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
